Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | DDO | Q99489 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10466274 | 0.96 | TDP1 (0.39) | TRPM4MEN1KMT2AMAPTGAA | |
| SCHEMBL11542686 | 0.83 | CA1 (0.46) | MEN1KMT2ATDP1HPGDCA1 | |
| SCHEMBL4259409 | 0.81 | CYP1A2 (0.45) | MEN1KMT2ATDP1CYP1A2NPC1 | |
| SCHEMBL1298115 | 0.79 | GRIN2D (0.53) | TRPM4MEN1KMT2ACYP1A2KDM4E | |
| SCHEMBL4353382 | 0.77 | CA1 (0.53) | TRPM4MEN1KMT2AGAANCOA3 | |
| SCHEMBL28653 | 0.74 | TRPM4 (0.57) | TRPM4MEN1KMT2AMAPTGAA | |
| SCHEMBL29750056 | 0.74 | TRPM4 (0.57) | TRPM4MEN1KMT2AMAPTGAA | |
| SCHEMBL29363675 | 0.74 | TRPM4 (0.57) | TRPM4MEN1KMT2AMAPTGAA | |
| SCHEMBL28500521 | 0.74 | CYP1A2 (0.39) | TRPM4MEN1KMT2AMAPTGAA | |
| SCHEMBL7378720 | 0.73 | IDO1 (0.45) | MEN1KMT2AMAPTGAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109486128-A | It is a kind of can laser color label plastic paper | 杨定吉甫 | 2019-03-19 | — | — | CN | claimed |
| CN-109354855-A | It is a kind of can laser color label rigid plastics | 杨定吉甫 | 2019-02-19 | — | — | CN | claimed |
| US-5620987-A | Amino acid derivatives | HOFFMANN-LA ROCHE INC. (US) | 1997-04-15 | — | — | US | claimed |
| US-5446161-A | Protease inhibitor, viricides | HOFFMANN-LA ROCHE INC. (US) | 1995-08-29 | — | — | US | claimed |
| EP-0559756-B1 | NONAPEPTIDE BOMBESIN ANTAGONISTS | UNIV TULANE (US) | 1995-04-05 | — | — | EP | claimed |
| EP-0346847-B1 | Amino acid derivatives | HOFFMANN LA ROCHE (CH) | 1994-05-11 | — | — | EP | claimed |
| EP-0559756-A1 | NONAPEPTIDE BOMBESIN ANTAGONISTS. | UNIV TULANE (US) | 1993-09-15 | — | — | EP | claimed |
| US-5244883-A | Treating cancer | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1993-09-14 | — | — | US | claimed |
| WO-1992009626-A1 | NONAPEPTIDE BOMBESIN ANTAGONISTS | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1992-06-11 | — | — | WO | claimed |
| EP-0346847-A2 | Amino acid derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1989-12-20 | — | — | EP | claimed |
| US-12043639-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| EP-4384508-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024031051-A1 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20240000966-A1 | Lipid Compositions For In Vivo Delivery | Life Technologies Corporation | 2024-01-04 | — | — | US | disclosed |
| WO-2024006937-A1 | LIPID COMPOSITIONS FOR IN VIVO DELIVERY | Life Technologies Corporation (US) | 2024-01-04 | — | — | WO | disclosed |
| EP-0346847-A2 | Amino acid derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1989-12-20 | — | — | EP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
| US-4652512-A | DIAZONIUM COMPOUND | KANZAKI PAPER MANUFACTURING COMPANY, LIMITED (JP) | 1987-03-24 | — | — | US | disclosed |
| EP-0084890-A1 | Diazotype heat development recording medium | Toppan Printing Co., Ltd. (JP) | 1983-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043639-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | TRPM4 2737/4885MEN1 604/4885KMT2A 489/4885 |
| US-20240000966-A1 | Lipid Compositions For In Vivo Delivery | CHMP4B, LIPA, CETP | TRPM4 4183/4885MEN1 1955/4885KMT2A 3841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.